应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02137 腾盛博药-B
未开盘 11-04 16:08:09
1.025
+0.045
+4.59%
最高
1.030
最低
0.970
成交量
102.00万
今开
0.980
昨收
0.980
日振幅
6.12%
总市值
7.40亿
流通市值
7.40亿
总股本
7.22亿
成交额
102.25万
换手率
0.14%
流通股本
7.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
腾盛博药-B:11月4日斥资32.22万港元回购32万股
南方财经网 · 11-04 21:40
腾盛博药-B:11月4日斥资32.22万港元回购32万股
腾盛博药-B:11月4日回购32.00万股股份,总额约32.22万港元
公告速递 · 11-04 21:36
腾盛博药-B:11月4日回购32.00万股股份,总额约32.22万港元
腾盛博药-B(02137)11月3日斥资30.21万港元回购30.25万股
智通财经 · 11-03 21:32
腾盛博药-B(02137)11月3日斥资30.21万港元回购30.25万股
腾盛博药-B 11月3日回购30.25万股,耗资约30.21万港元
公告速递 · 11-03 21:25
腾盛博药-B 11月3日回购30.25万股,耗资约30.21万港元
腾盛博药-B回购6.25万股股份,总额约6.23万港元
公告速递 · 11-02 18:01
腾盛博药-B回购6.25万股股份,总额约6.23万港元
腾盛博药-B(02137)11月2日斥资6.23万港元回购6.25万股
智通财经 · 11-02 17:58
腾盛博药-B(02137)11月2日斥资6.23万港元回购6.25万股
腾盛博药生物科技有限公司10月30日回购28.3万股并向员工增发5,875股
公告速递 · 10-30
腾盛博药生物科技有限公司10月30日回购28.3万股并向员工增发5,875股
腾盛博药-B(02137)10月30日斥资27.44万港元回购28.3万股
智通财经 · 10-30
腾盛博药-B(02137)10月30日斥资27.44万港元回购28.3万股
腾盛博药-B:李安康减持,好仓比例降至1.25%
港股披露 · 10-30
腾盛博药-B:李安康减持,好仓比例降至1.25%
腾盛博药-B于10月29日回购54,000股并发行271,700股
公告速递 · 10-29
腾盛博药-B于10月29日回购54,000股并发行271,700股
腾盛博药-B:10月28日回购25.5万股并发行逾11万股新股
公告速递 · 10-28
腾盛博药-B:10月28日回购25.5万股并发行逾11万股新股
腾盛博药-B(02137)10月28日斥资约24.27万港元回购25.5万股
智通财经 · 10-28
腾盛博药-B(02137)10月28日斥资约24.27万港元回购25.5万股
腾盛博药-B于10月27日回购13.15万股股份,总额约12.37万港元
公告速递 · 10-27
腾盛博药-B于10月27日回购13.15万股股份,总额约12.37万港元
腾盛博药-B:10月26日回购11万股,耗资约10.09万港元
公告速递 · 10-26
腾盛博药-B:10月26日回购11万股,耗资约10.09万港元
腾盛博药-B(02137)10月26日耗资约10.09万港元回购11万股
智通财经 · 10-26
腾盛博药-B(02137)10月26日耗资约10.09万港元回购11万股
腾盛博药-B(02137.HK)10月26日耗资约10.09万港元回购11万股
智通财经 · 10-26
腾盛博药-B(02137.HK)10月26日耗资约10.09万港元回购11万股
腾盛博药-B(02137.HK)10月23日斥资6.98万港元回购7.8万股
智通财经 · 10-23
腾盛博药-B(02137.HK)10月23日斥资6.98万港元回购7.8万股
腾盛博药-B回购78,000股普通股,涉资约6.98万港元
公告速递 · 10-23
腾盛博药-B回购78,000股普通股,涉资约6.98万港元
腾盛博药-B:10月22日回购54,500股,涉资约4.90万港元
公告速递 · 10-22
腾盛博药-B:10月22日回购54,500股,涉资约4.90万港元
腾盛博药-B(02137)10月22日斥资4.9万港元回购5.45万股
智通财经 · 10-22
腾盛博药-B(02137)10月22日斥资4.9万港元回购5.45万股
加载更多
公司概况
公司名称:
腾盛博药-B
所属市场:
SEHK
上市日期:
--
主营业务:
腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。该公司研发的产品主要包括乙型肝炎病(HBV)免疫治疗候选药物BRII-179、靶向乙型肝炎表面抗原(HBsAg)的研究性HBV中和单克隆抗体Tobevibart、以及用于治疗多重耐药性(MDR)和广泛耐药性(XDR)的革兰氏阴性菌感染的合成脂肽soralimixin(BRII-693)等。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":1.025,"timestamp":1793779689050,"preClose":0.98,"halted":0,"volume":1020000,"delay":0,"changeRate":0.0459183673469387,"floatShares":722000000,"shares":722000000,"eps":-0.308397,"marketStatus":"未开盘","change":0.045,"latestTime":"11-04 16:08:09","open":0.98,"high":1.03,"low":0.97,"amount":1022537,"amplitude":0.061224,"askPrice":1.025,"askSize":31000,"bidPrice":1.01,"bidSize":48000,"shortable":0,"etf":0,"ttmEps":-0.277975,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":0,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":0.98,"openAndCloseTimeList":[[1793755800000,1793764800000],[1793768400000,1793779200000]],"volumeRatio":1.0399673736150068,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"2680525640","title":"腾盛博药-B:11月4日斥资32.22万港元回购32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680525640","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680525640?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:40","pubTimestamp":1793799642,"startTime":"0","endTime":"0","summary":"南财智讯11月4日电,腾盛博药-B(02137.HK)发布翌日披露报表,11月4日,公司回购32万股,每股最高回购价1.03港元,每股最低回购价0.99港元,付出的总代价为32.22万港元。本次回购股份拟持作库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611043922238751.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611043922238751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02137","BK1574","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160069394","title":"腾盛博药-B:11月4日回购32.00万股股份,总额约32.22万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160069394","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160069394?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:36","pubTimestamp":1793799374,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年11月4日公告,称当天在香港联交所回购普通股32.00万股,占本次购回前已发行股本的0.0444%。此次回购的每股价格介乎0.99港元至1.03港元,总对价为322,160港元。回购完成后,公司已发行股份数量变更为720,582,157股,库藏股份数目为15,261,500股,总发行股份数则保持于735,843,657股。公司依据2026年6月16日通过的购回授权可回购股份总数为72,185,205股,截至目前已累计回购2,538,000股。公司表示已遵守香港联交所证券上市规则及有关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B:11月4日回购32.00万股股份,总额约32.22万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680628724","title":"腾盛博药-B(02137)11月3日斥资30.21万港元回购30.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680628724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680628724?lang=zh_cn&edition=full","pubTime":"2026-11-03 21:32","pubTimestamp":1793712757,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布公告,该公司于2026年11月3日斥资30.21万港元回购30.25万股股份,每股回购价格为0.98-1.005港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","02137","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111147299","title":"腾盛博药-B 11月3日回购30.25万股,耗资约30.21万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111147299","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111147299?lang=zh_cn&edition=full","pubTime":"2026-11-03 21:25","pubTimestamp":1793712352,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年11月3日发布公告,披露当日通过香港联合交易所场内回购股份30.25万股,约占该公司现有已发行股本的0.0419%。本次回购价介乎每股0.98港元至1.005港元,合计支付约30.21万港元。经本次回购后,公司已发行股份数量由2026年11月2日的721,204,657股降至720,902,157股,库藏股数则由14,639,000股增至14,941,500股,合计股份总数维持为735,843,657股。公告显示,公司先前于2026年6月16日通过购回授权,拟可回购最多72,185,205股。本公告由腾盛博药-B联席公司秘书李安康博士签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B 11月3日回购30.25万股,耗资约30.21万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119681559","title":"腾盛博药-B回购6.25万股股份,总额约6.23万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119681559","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119681559?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:01","pubTimestamp":1793613686,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年11月2日发布翌日披露报表,公布最新股份购回情况。公司于2026年11月2日在香港联交所场内回购股份共62,500股,占回购前已发行股份总数约0.0087%,每股回购价介乎0.99港元至1.005港元之间,合计耗资约6.23万港元。本次回购完成后,公司已发行股本总数维持735,843,657股不变,其中流通股减少至721,204,657股,库藏股增加至14,639,000股。公司确认本次回购严格遵守香港联交所《证券上市规则》及相关法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B回购6.25万股股份,总额约6.23万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680758548","title":"腾盛博药-B(02137)11月2日斥资6.23万港元回购6.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680758548","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680758548?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:58","pubTimestamp":1793613533,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布公告,该公司于2026年11月2日斥资6.23万港元回购6.25万股股份,每股回购价格为0.99-1.005港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1161","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184704484","title":"腾盛博药生物科技有限公司10月30日回购28.3万股并向员工增发5,875股","url":"https://stock-news.laohu8.com/highlight/detail?id=1184704484","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184704484?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:36","pubTimestamp":1793367365,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月30日发布公告称,当日通过香港联交所场内回购公司普通股283,000股,占回购前已发行股份约0.0392%。同日,公司因行使2023年股份奖励计划向员工额外发行5,875股普通股,约占当日交易前已发行股本的0.0008%。根据公告,腾盛博药生物科技有限公司的回购行为系依据2026年6月16日获股东大会批准的回购授权进行,公司最多可回购72,185,205股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药生物科技有限公司10月30日回购28.3万股并向员工增发5,875股","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679217629","title":"腾盛博药-B(02137)10月30日斥资27.44万港元回购28.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679217629","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679217629?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:34","pubTimestamp":1793367253,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布公告,于2026年10月30日斥资27.44万港元回购28.3万股;因行使根据本公司于2023年9月1日采纳的2023年股份奖励计划授出的受限制股份单位归属,而向本公司雇员发行及配发5875股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1161","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123035007","title":"腾盛博药-B:李安康减持,好仓比例降至1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123035007","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123035007?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:31","pubTimestamp":1793352683,"startTime":"0","endTime":"0","summary":"李安康于2026年10月30日在联交所场内以每股均价0.96港元卖出腾盛博药-B(02137)股份3.35万股,涉资约3.22万港元。该笔属于场内主动交易,即在二级市场直接买卖股份。李安康此次减持前持有腾盛博药-B好仓926.80万,占比1.26%;减持后持股量为923.45万,好仓比例降至1.25%。原文链接:Hong Kong Exchanges and Clearing Limited。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120846161","title":"腾盛博药-B于10月29日回购54,000股并发行271,700股","url":"https://stock-news.laohu8.com/highlight/detail?id=1120846161","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120846161?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:46","pubTimestamp":1793277961,"startTime":"0","endTime":"0","summary":"2026年10月29日,腾盛博药-B发布翌日披露报表,宣布当日于香港联交所场内回购54,000股普通股,并根据2023年股份奖励计划发行合计271,700股新股。公司于2026年10月28日的已发行股份数为721,326,582股,库存股份为14,239,500股。上述交易完成后,公司已发行股份增至721,544,282股,库存股份增加至14,293,500股,总发行股份数达735,837,782股。公告显示,腾盛博药-B的回购授权于2026年6月16日获股东大会通过,授权回购上限为72,185,205股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B于10月29日回购54,000股并发行271,700股","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189986873","title":"腾盛博药-B:10月28日回购25.5万股并发行逾11万股新股","url":"https://stock-news.laohu8.com/highlight/detail?id=1189986873","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189986873?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:21","pubTimestamp":1793193704,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月28日披露翌日报表,宣布当日在香港联交所回购股份及向员工发行新股,涉及已发行股本与库藏股数量的变动。上述交易完成后,公司于2026年10月28日的已发行股份总数为721,326,582股,库藏股数目增加至14,239,500股。腾盛博药-B表示,此次股份回购根据其于2026年6月16日通过的回购授权进行,该授权允许公司回购最多72,185,205股,截至本次交易前已累计回购1,516,000股,占授权通过当日已发行股本约0.21%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B:10月28日回购25.5万股并发行逾11万股新股","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678495599","title":"腾盛博药-B(02137)10月28日斥资约24.27万港元回购25.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678495599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678495599?lang=zh_cn&edition=full","pubTime":"2026-10-28 21:20","pubTimestamp":1793193650,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布公告,于2026年10月28日该公司斥资约24.27万港元回购25.5万股,回购价格为每股0.935至0.955港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02137","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108629139","title":"腾盛博药-B于10月27日回购13.15万股股份,总额约12.37万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108629139","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108629139?lang=zh_cn&edition=full","pubTime":"2026-10-27 20:16","pubTimestamp":1793103371,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月27日公告,当日在香港联交所场内回购普通股合计131,500股,占公司现有已发行股本的0.0182%。本次回购每股价格介乎0.92港元至0.95港元,总涉资约12.37万港元。回购完成后,公司已发行股份数目变更为721,468,832股,库藏股份增至13,984,500股,合计已发行股本仍为735,453,332股。截至目前,公司已累计在香港联交所或其他证券交易所回购1,261,000股。公司确认本次回购已遵守香港联交所上市规则及相关法律法规的规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B于10月27日回购13.15万股股份,总额约12.37万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117155801","title":"腾盛博药-B:10月26日回购11万股,耗资约10.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117155801","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117155801?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:46","pubTimestamp":1793026016,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月26日公告称,公司当日在香港联合交易所场内回购普通股共110,000股,占当日公司现有已发行股本约0.0152%。本次回购价格介乎每股0.90港元至0.935港元,合计涉资约10.09万港元。同日,公司因行使2023年9月1日采纳的2023年股份奖励计划所授出的受限制股份单位归属,向公司员工分别发行及配发57,750股和74,950股普通股,分别占当日公司现有已发行股本约0.008%和0.0104%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B:10月26日回购11万股,耗资约10.09万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678910061","title":"腾盛博药-B(02137)10月26日耗资约10.09万港元回购11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678910061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678910061?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:37","pubTimestamp":1793025447,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)公布,2026年10月26日耗资约10.09万港元回购11万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02137","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678191009","title":"腾盛博药-B(02137.HK)10月26日耗资约10.09万港元回购11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678191009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678191009?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:37","pubTimestamp":1793025447,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02137","BK1161","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677978444","title":"腾盛博药-B(02137.HK)10月23日斥资6.98万港元回购7.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677978444","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677978444?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:19","pubTimestamp":1792765164,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02137","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122537826","title":"腾盛博药-B回购78,000股普通股,涉资约6.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122537826","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122537826?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:11","pubTimestamp":1792764715,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月23日公告回购普通股78,000股,占本次回购前公司已发行股本约0.0108%。回购价格介乎每股港币0.88元至0.915元,总耗资约6.98万港元。回购完成后,公司已发行股本总数维持735,320,632股,其中剔除库藏股后为721,577,632股,库藏股数量增至13,743,000股。公司已在香港联交所或其他证券交易所累计回购1,019,500股,占购回授权的0.1412%。公司同时确认本次回购遵守了香港联交所证券上市规则及其他相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B回购78,000股普通股,涉资约6.98万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153116742","title":"腾盛博药-B:10月22日回购54,500股,涉资约4.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153116742","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153116742?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:00","pubTimestamp":1792677644,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年10月22日发布公告,披露当日在香港联交所场内回购公司普通股54,500股。每股回购价介乎港币0.88港元至0.915港元,合计支付约4.90万港元。本次交易完成后,公司已发行股本由原有的721,710,132股减少至721,655,632股,库藏股增至13,665,000股。此前,腾盛博药-B已于2026年6月16日通过股份购回授权,授权购回股份总数为72,185,205股。截至本次回购,公司在香港联交所及其他证券交易所共计回购941,500股,占授权当日已发行股本总数约0.1304%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B:10月22日回购54,500股,涉资约4.90万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677691829","title":"腾盛博药-B(02137)10月22日斥资4.9万港元回购5.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677691829","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677691829?lang=zh_cn&edition=full","pubTime":"2026-10-22 21:59","pubTimestamp":1792677540,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布公告,于2026年10月22日斥资4.9万港元回购5.45万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":0.1782},{"period":"3month","weight":0.1081},{"period":"6month","weight":-0.2351},{"period":"1year","weight":-0.4519},{"period":"ytd","weight":-0.273}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。该公司研发的产品主要包括乙型肝炎病(HBV)免疫治疗候选药物BRII-179、靶向乙型肝炎表面抗原(HBsAg)的研究性HBV中和单克隆抗体Tobevibart、以及用于治疗多重耐药性(MDR)和广泛耐药性(XDR)的革兰氏阴性菌感染的合成脂肽soralimixin(BRII-693)等。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040695},{"month":2,"riseRate":0.6,"avgChangeRate":0.049398},{"month":3,"riseRate":0.2,"avgChangeRate":-0.163076},{"month":4,"riseRate":0.2,"avgChangeRate":-0.015797},{"month":5,"riseRate":0,"avgChangeRate":-0.081235},{"month":6,"riseRate":0.2,"avgChangeRate":-0.107834},{"month":7,"riseRate":0.8,"avgChangeRate":0.07356},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.000001},{"month":9,"riseRate":0.5,"avgChangeRate":-0.011255},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.084385},{"month":11,"riseRate":0.666667,"avgChangeRate":0.24624},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154392}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}